GERMS
Tuesday, January 21, 2014
ViiV Healthcare’s new HIV medicine TivicayTM (dolutegravir) is approved in Europe | 2014 | Press releases | Media | GlaxoSmithKline
ViiV Healthcare’s new HIV medicine TivicayTM (dolutegravir) is approved in Europe | 2014 | Press releases | Media | GlaxoSmithKline
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
‹
›
Home
View web version
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.